MKI67 and breast cancer: Additionally, our findings are in line with previous studies in patients with EBC that have demonstrated a relationship between SUVmax and several classical clinicopathological characteristics such as clinical stage [14], HR status [15, 16], Ki67 proliferation index [11, 17], tumor size [18], and histological grade [19–21] regardless of BC subtype.